Ceftriaxone impurity A

Get a Price/Quote

MOQ : 1 Kilograms

Ceftriaxone impurity A Specification

Melting Point
>155 °C

Molecular Weight
554.6 Grams (g)

Usage
Ceftriaxone. Ceftriaxone (ceftriaxone sodium and dextrose) Injection is an antibacterial drug used to treat conditions such as lower respiratory tract infections, skin and skin structure infections, urinary tract infections, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, and meningitis.

Molecular Formula
C18H16N8Na2O7S

Purity
93%

Ceftriaxone impurity A Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Kilograms Per Month

Delivery Time
3-4 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Main Export Market(s)
Western Europe, Australia, North America, South America, Eastern Europe, Middle East, Africa, Central America, Asia

Main Domestic Market
All India

About Ceftriaxone impurity A

Ceftriaxone impurity A Synonym: (6R,7R)-7-[[(2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2-methyl-5, 6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid CAS Number 92143-31-2 Empirical Formula (Hill Notation) C18H18N8O7S3 Molecular Weight 554.58form neat format neat

FAQs of Ceftriaxone impurity A:

Q: What is the molecular formula of Ceftriaxone impurity A?

A: The molecular formula of Ceftriaxone impurity A is C18H16N8Na2O7S.

Q: What is the molecular weight of Ceftriaxone impurity A?

A: The molecular weight of Ceftriaxone impurity A is 554.6 grams (g).

Q: What is the purity level of Ceftriaxone impurity A?

A: The purity level of Ceftriaxone impurity A is 93%.

Q: What is the melting point of Ceftriaxone impurity A?

A: The melting point of Ceftriaxone impurity A is greater than 155 C.

Q: What is the usage of Ceftriaxone impurity A?

A: Ceftriaxone impurity A is used in Ceftriaxone, an antibacterial drug for the treatment of conditions such as lower respiratory tract infections, skin and skin structure infections, urinary tract infections, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, and meningitis.

Tell us about your requirement